Skip to Content

M RE 150 (Risedronate Sodium 150 mg)

Pill with imprint M RE 150 is Blue, Round and has been identified as Risedronate Sodium 150 mg. It is supplied by Mylan Pharmaceuticals Inc..

Risedronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M RE 150

Risedronate sodium 150 mg M RE 150

Risedronate Sodium

Imprint
M RE 150
Strength
150 mg
Color
Blue
Shape
Round
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-4150

Get help with Imprint Code FAQs.

Related Images for "M RE 150"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.